Evidence map›Paper›PMID 24391530›Full record

ArticleFrontiers in neuroscience2013

Differential actions of orexin receptors in brainstem cholinergic and monoaminergic neurons revealed by receptor knockouts: implications for orexinergic signaling in arousal and narcolepsy.

Kristi A Kohlmeier, Christopher J Tyler, Mike Kalogiannis, Masaru Ishibashi, Morten P Kristensen, Iryna Gumenchuk, Richard M Chemelli, Yaz Y Kisanuki, Masashi Yanagisawa, Christopher S Leonard

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. GABA Cells in the Central Nucleus of the Amygdala Promote Cataplexy.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Kristi A KohlmeierDepartment of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen Copenhagen, Denmark.
Christopher J TylerDepartment of Physiology, New York Medical College Valhalla, NY, USA.
Mike KalogiannisDepartment of Physiology, New York Medical College Valhalla, NY, USA.
Masaru IshibashiDepartment of Physiology, New York Medical College Valhalla, NY, USA.
Morten P KristensenDepartment of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen Copenhagen, Denmark.
Iryna GumenchukDepartment of Physiology, New York Medical College Valhalla, NY, USA.
Richard M ChemelliHoward Hughes Medical Institute, University of Texas Southwestern Medical Center Dallas, TX, USA.
Yaz Y KisanukiHoward Hughes Medical Institute, University of Texas Southwestern Medical Center Dallas, TX, USA.
Masashi YanagisawaHoward Hughes Medical Institute, University of Texas Southwestern Medical Center Dallas, TX, USA.
Christopher S LeonardDepartment of Physiology, New York Medical College Valhalla, NY, USA.
New York Medical College · USThe University of Texas Southwestern Medical Center · USUniversity of Copenhagen · DKHoward Hughes Medical Institute · US

Funding

"Synaptic Modulation of Mesopontine Cholingergic Neurons"R01NS027881 · NINDS · NEW YORK UNIVERSITY · PI LEONARD, CHRISTOPHER S · 1992 to 2022
$7.1M
K+-CHANNELS REGULATING REM-RELATED CHOLINGERGIC NEURONSR01HL064150 · NHLBI · NEW YORK MEDICAL COLLEGE · PI LEONARD, CHRISTOPHER S · 1999 to 2011
$2.6M
NHLBI NIH HHS R01 HL064150NINDS NIH HHS R01 NS027881
6 · The paper itself

Abstract

Orexin neuropeptides influence multiple homeostatic functions and play an essential role in the expression of normal sleep-wake behavior. While their two known receptors (OX1 and OX2) are targets for novel pharmacotherapeutics, the actions mediated by each receptor remain largely unexplored. Using brain slices from mice constitutively lacking either receptor, we used whole-cell and Ca(2+) imaging methods to delineate the cellular actions of each receptor within cholinergic [laterodorsal tegmental nucleus (LDT)] and monoaminergic [dorsal raphe (DR) and locus coeruleus (LC)] brainstem nuclei-where orexins promote arousal and suppress REM sleep. In slices from OX(-/-) 2 mice, orexin-A (300 nM) elicited wild-type responses in LDT, DR, and LC neurons consisting of a depolarizing current and augmented voltage-dependent Ca(2+) transients. In slices from OX(-/-) 1 mice, the depolarizing current was absent in LDT and LC neurons and was attenuated in DR neurons, although Ca(2+)-transients were still augmented. Since orexin-A produced neither of these actions in slices lacking both receptors, our findings suggest that orexin-mediated depolarization is mediated by both receptors in DR, but is exclusively mediated by OX1 in LDT and LC neurons, even though OX2 is present and OX2 mRNA appears elevated in brainstems from OX(-/-) 1 mice. Considering published behavioral data, these findings support a model in which orexin-mediated excitation of mesopontine cholinergic and monoaminergic neurons contributes little to stabilizing spontaneous waking and sleep bouts, but functions in context-dependent arousal and helps restrict muscle atonia to REM sleep. The augmented Ca(2+) transients produced by both receptors appeared mediated by influx via L-type Ca(2+) channels, which is often linked to transcriptional signaling. This could provide an adaptive signal to compensate for receptor loss or prolonged antagonism and may contribute to the reduced severity of narcolepsy in single receptor knockout mice.

Indexed as

Ca2+ signalingdorsal raphe nucleuslaterodorsal tegmental nucleuslocus coeruleuswhole-cell patch-clamp recording

Identifiers

PMID24391530
PMCPMC3869224
OpenAlexW2047202956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.